The global wearable injectors market is anticipated to grow at a considerable CAGR of 11.8% during the forecast period. The key factors that are contributing to the market growth are the increasing adoption of several strategies adopted by key players operating the market such as new technology-based product development, new plant setup, acquisition, mergers, and collaboration among other. Tus attributed to it to expand globally and remain competitive in the market are such factors driving wearable market growth further. For instance,
Browse the full report description of “Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On Body, And Off Body), by Technology (Electronic Injector, Mechanical Injector, and Others), by Mechanism of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, And Pressurized Gas), by Application (Oncology, Infectious Disease, Autoimmune Disease, Cardiovascular Disease, Blood Disorder, And Others) by and End-User (Hospital, Lab And Diagnostics Clinics, Homecare Settings, and Others), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/wearable-injectors-market
• In February 2022, BD (Becton, Dickinson, and Co.), has stated that it has completed a 50-subject human clinical trial with the BD Libertas Wearable Injector. The newly developed injector is a subcutaneous drug delivery system that is designed to require no patient assembly and deliver biologics with viscosities.
• In February 2022, Cambridge Consultants designed Plug & Play Wearable Injector that simplifies the biological drug delivery system. These newly developed devices allow orientation independent delivery and offer business technology consultancy and licenses for intellectual property.
• In November 2021, researchers at the University of Washington (UW) developed a wearable device that detects and reverse an opioid overdose. The UW investigators worked on the prototype with West Pharmaceutical Services of Exton, Penn, which developed a wearable subcutaneous injector.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Technology
o By Mechanism Of Injection
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Becton, Dickinson and Co., Bühler Motor GmbH, E3D Elcam Drug Delivery Devices, Medtronic, Swiss Medical Technology Co., United Therapeutics Corp., Ypsomed AG, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Wearable Injectors Market Report Segment
By Type
By Technology
By Mechanism Of Injection
By Application
By End-User
Global Wearable Injectors Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/wearable-injectors-market